Nontuberculous Mycobacterial Lung Disease (NTM-LD): Overcoming Common Pitfalls in Diagnosis and Treatment

Nontuberculous Mycobacterial Lung Disease (NTM-LD): Overcoming Common Pitfalls in Diagnosis and Treatment is organized by Med Learning Group.

Release Date: June 01, 2022
Expiration Date: June 01, 2023

Program Overview:
This enduring activity will explore the diagnosis and management of NTM-LD. Whiteboard animations will identify common pitfalls that lead to delays in diagnosis and look at the mechanism of action of novel therapies for refractory disease. A case-based didactic lecture led by expert faculty will review guideline-recommended care, strategies to minimize adverse events, and clinical trial data on newer treatment options.

Learning Objectives:
After completing this activity, learners should be better able to:
• Reduce time to diagnosis in patients with suspected NTM-LD
• Individualize treatment selection for patients with NTM-LD in frontline and refractory settings based on clinical guidelines and patient characteristics
• Evaluate the role of amikacin liposome inhalation suspension (ALIS) in the treatment of patients with NTM-LD
• Optimize strategies to avoid and manage the adverse effects of antibiotic therapy in patients with NTM-LD and facilitate the completion of therapy